Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Journal of Hypertension|November 27, 2009
Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive ratsAgnieszka Walkowska, Petra Skaroupková, Zuzana Husková, et al.Clinical and Experimental Pharmacology & Physiology|September 17, 2014
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic ratsAlexandra Sporková, Sárka Jíchová, Zuzana Husková, et al.Clinical Science (London, England : 1979)|February 14, 2012
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertensionJan Neckář, Libor Kopkan, Zuzana Husková, et al.Journal of Hypertension|July 2, 2011
Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic ratsZuzana Honetschlägerová, Alexandra Sporková, Libor Kopkan, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 14, 2017
Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive ratsLenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, et al.Vascular Pharmacology|July 3, 2007
Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic ratsVera Certíková Chábová, Herbert J Kramer, Ivana Vanecková, et al.Kidney & Blood Pressure Research|November 13, 2010
Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin IIDan Rakušan, Marcela Bürgelová, Ivana Vaněčková, et al.Journal of Hypertension|July 19, 2016
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic ratsŠárka Jíchová, Libor Kopkan, Zuzana Husková, et al.Journal of Hypertension|January 12, 2013
Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAMEZuzana Honetschlägerová, Kento Kitada, Zuzana Husková, et al.Clinical Science (London, England : 1979)|January 7, 2010
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic ratsVera Certíková Chábová, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, et al.Pageof 6